New Delhi: The indigenous anti-Covid-19 vaccine ‘Covaxin’ developed by Hyderabad-based Bharat Biotech will have to wait a few more days to get the approval of the World Health Organization (WHO). The World Health Organization has once again extended the date of the meeting to be held to approve the vaccine. This meeting will now be held on October 5. According to the news agency ANI, members of the World Health Organization’s group SAGE on Covid Vaccine and members of Bharat Biotech, which manufactures the vaccine, will be present in the meeting to be held in October 5.
The WHO has so far approved emergency use of vaccines manufactured by major US pharmaceutical companies Pfizer-BioNTech, Johnson & Johnson, Moderna, China’s Sinopharm, and Oxford-AstraZeneca. Covaccine is one of six vaccines that have received emergency use approval from India’s drug regulator and are being used along with Kovishield and Sputnik V in a nationwide immunization program.
Let us tell you that the command of the world’s largest vaccination campaign going on in India is mainly with Covishield of Serum Institute and Covaccine of Bharat Biotech. So far 79 crore people in India have been given the corona vaccine. Comparing these two vaccines, more than 69 crore people have been covashield while more than 9 crore people have been given vaccines. Covishield has already received approval from the World Health Organization (WHO) while Covaccine is still awaiting WHO approval.
Bharat Biotech gave data related to vaccines to WHO
Bharat Biotech said a day earlier than it has submitted all data related to its Covid-19 vaccine to the World Health Organization (WHO) for emergency use list (EUL) and is now awaiting feedback from the global health organization. . WHO is currently reviewing data from Bharat Biotech.
